Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001193125-22-215187
Filing Date
2022-08-09
Accepted
2022-08-08 18:58:14
Documents
6
Effectiveness Date
2022-08-09

Document Format Files

Seq Description Document Type Size
1 S-8 d396007ds8.htm S-8 35196
2 EX-5.1 d396007dex51.htm EX-5.1 6878
3 EX-23.1 d396007dex231.htm EX-23.1 1674
4 EX-99.1 d396007dex991.htm EX-99.1 130903
5 EX-FILING FEES d396007dexfilingfees.htm EX-FILING FEES 15382
6 GRAPHIC g396007g0808224305167.jpg GRAPHIC 2426
  Complete submission text file 0001193125-22-215187.txt   194564
Mailing Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DRIVE SUITE 300 SAN DIEGO CA 92130 858-558-2871
ACADIA PHARMACEUTICALS INC (Filer) CIK: 0001070494 (see all company filings)

EIN.: 061376651 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-266680 | Film No.: 221145929
SIC: 2834 Pharmaceutical Preparations